Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040084A1 Salts of paroxetine
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040079A1 Synthesis of dysidiolide and uses thereof
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999040072A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents
08/12/1999WO1999040069A1 Benzyloxy prodigiosine compounds
08/12/1999WO1999040068A2 2-aminoquinoline derivatives having d4-agonistic activity
08/12/1999WO1999040067A2 Benzisoxazole derivatives having d4-antagonistic activity
08/12/1999WO1999040064A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999WO1999040061A2 Novel dihydroxyhexanoic acid derivatives
08/12/1999WO1999040056A1 Hydroxylation activated prodrugs
08/12/1999WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/12/1999WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999WO1999039736A2 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
08/12/1999WO1999039732A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
08/12/1999WO1999039728A2 Methods of inducing hair growth and coloration
08/12/1999WO1999039721A1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
08/12/1999WO1999039720A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999WO1999039719A1 Preventives and remedies for ischemic reflow disorder
08/12/1999WO1999039718A1 Medicine for treating apoptosis dysfunction containing oligosaccharides
08/12/1999WO1999039716A1 Preventives and remedies for neuron digeneration-associated diseaseas
08/12/1999WO1999039715A1 Readily absorbable phytosterols to treat hypercholesterrolemia
08/12/1999WO1999039714A1 Remedies for neurological disorders
08/12/1999WO1999039713A1 Piroxicam-containing hydroalcoholic gel composition
08/12/1999WO1999039712A1 Substituted semicarbazides and the use thereof
08/12/1999WO1999039711A1 Antimicrobial composition
08/12/1999WO1999039710A1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
08/12/1999WO1999039709A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999WO1999039708A1 Tablets to be crunched or sucked, comprising iron as active principle
08/12/1999WO1999039707A1 Metal-thiols as immunomodulating agents
08/12/1999WO1999039706A1 Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy
08/12/1999WO1999039705A1 Wound-healing composition and method
08/12/1999WO1999039704A1 Antibacterial agents
08/12/1999WO1999039703A1 Preventives and remedies for intestinal mucosal disorder
08/12/1999WO1999039702A2 Method for regulating size and growth of vascularized normal tissue
08/12/1999WO1999039700A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
08/12/1999WO1999039699A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
08/12/1999WO1999039696A1 Propofol composition containing sulfite
08/12/1999WO1999039695A1 Emulsion for transdermal administration of an active principle
08/12/1999WO1999039694A2 Compositions containing organic compounds
08/12/1999WO1999039691A2 Pharmaceutical compositions
08/12/1999WO1999039682A2 Lipid mixtures and their use
08/12/1999WO1999039647A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999WO1999039580A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use
08/12/1999WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999WO1999027919A3 Cyp2a enzymes and their use in therapeutic and diagnostic methods
08/12/1999WO1999027916A3 Method for producing solid dosing forms
08/12/1999WO1999026940A3 Method for producing 8-methoxy-quinoline carboxylic acids
08/12/1999WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
08/12/1999WO1999026589A3 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
08/12/1999WO1999024471A9 Opiate, cannabinoid, and estrogen receptors
08/12/1999WO1999022745A8 Cross-linked copolymers containing aminophosphonium groups for medical applications
08/12/1999WO1999022593A9 Use of exochelins in the preservation of organs for transplant
08/12/1999WO1999018195A3 Methods and compositions for inducing tumor-specific cytotoxicity
08/12/1999WO1999008657A3 Self-binding shearform compositions
08/12/1999WO1999006032A3 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
08/12/1999WO1999004822A3 New salts with beneficial organoleptic properties
08/12/1999WO1999003446A3 Antimicrobial cosmetic compositions
08/12/1999WO1999002143A3 Medicament comprising adenosine
08/12/1999WO1999002132A3 Use of submicron oil-in-water emulsions with dna vaccines
08/12/1999WO1999002130A3 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
08/12/1999WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999WO1999000114A3 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
08/12/1999WO1998058633A3 Microdose therapy of vascular conditions by no donors
08/12/1999WO1998057662A3 Therapeutic systems
08/12/1999WO1998049146A3 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
08/12/1999WO1998048784A3 Method and composition for modulating amyloidosis
08/12/1999WO1998008505A8 Pharmaceutical compounds
08/12/1999WO1996037199A8 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
08/12/1999DE19805117A1 Neue Oxazolidinone mit azolhaltigen Tricyclen Novel oxazolidinones with azole tricycles
08/12/1999CA2321257A1 Remedies for neurological disorders
08/12/1999CA2321175A1 Method of screening therapeutic agents
08/12/1999CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999CA2320625A1 45 human secreted proteins
08/12/1999CA2320483A1 Methods of inducing hair growth and coloration
08/12/1999CA2320476A1 Antibacterial agents
08/12/1999CA2320475A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999CA2320300A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999CA2319677A1 Medicine for treating apoptosis dysfunction containing oligosaccharides
08/12/1999CA2319664A1 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
08/12/1999CA2319652A1 Salts of paroxetine
08/12/1999CA2319567A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999CA2319565A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
08/12/1999CA2319555A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999CA2319494A1 5-membered heterocyclic condensed benzoderivatives, the preparation thereof and their use as pharmaceuticals
08/12/1999CA2319484A1 Substituted semicarbazides and the use thereof
08/12/1999CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999CA2319356A1 Composition and methods for treatment of hiv infection
08/12/1999CA2319086A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999CA2319020A1 Pharmaceutical compositions for prevention and treatment of neurodegenarative diseases
08/12/1999CA2319011A1 Tablets to be crunched or sucked, comprising iron as active principle
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
1 ... 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 ... 7860